Vaccination

Glaxo, SK bioscience start final trial of COVID jab

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have begun final stage trials of a COVID-19 jab after positive early results, they announced Tuesday.

Medical research

One-step method to generate mice for vaccine research

To develop vaccines and investigate human immune responses, scientists rely on a variety of animal models, including mice that can produce human antibodies through genetically engineered B cell receptors, which are specialized ...

Diseases, Conditions, Syndromes

President Biden to end COVID-19 emergencies on May 11

President Joe Biden informed Congress on Monday that he will end the twin national emergencies for addressing COVID-19 on May 11, as most of the world has returned closer to normalcy nearly three years after they were first ...

Vaccination

Europe pause of AstraZeneca sends ripple of doubt elsewhere

The suspension of the AstraZeneca vaccine in several European countries over the past week could fuel skepticism about the shot far beyond their shores, potentially threatening the rollout of a vaccine that is key to the ...

Vaccination

UN urges more vaccines for Africa, with only 2 percent now

The U.N. Security Council called for accelerated availability of coronavirus vaccines for Africa on Wednesday, expressing concern that the continent has received only about 2% of all doses administered globally.

page 28 from 35